Evaluation of Safety and Efficacy of the Accero® (Heal) Stent for Intracranial Aneurysm Treatment

NCT03957382 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-11-21

No results posted yet for this study

Summary

This study is intended to show that the application of the Accero® (heal) stent is safe within the given indication.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Accero® (heal) Stent

The Accero® (heal) Stent will only be used in line with the Instructions For Use (IFU). Patients participating in this PMCF (Post- Market Clinical Follow-up) will not be exposed to any additional risk. There are no additional treatments or investigations other than done in the clinical routine.

Sponsors & Collaborators

  • Acandis GmbH

    lead INDUSTRY

Principal Investigators

  • Maxim Bester, PD. Dr. · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-23
Primary Completion
2029-03-01
Completion
2029-03-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03957382 on ClinicalTrials.gov